Hearing aid deal faces battle for clearance after CMA in-depth probe

The UK’s Competition and Markets Authority has said proposed behavioural commitments are unlikely to remedy its concerns about Cochlear’s €111 million purchase of Oticon Medical, warning that even the full divestment of the overlapping business might not fix the harm.

Unlock unlimited access to all Global Competition Review content